Company: Research Group Applied Natural Sciences
Project needs: Accelerated Molecular Detection of Chlamydia trachomatis (CT)
Our Solution: Due to NextGenPCR, the time-to-result for CT from patient material has been accelerated compared to conventional real-time PCR.
The research group of Applied Natural Sciences from Fontys University (The Netherlands) focuses on five research fields: Thin Films and Functional Materials (Dr. Jan Bernards), Solar Fuels (Dr. Peter Thüne), Detection and Measurement (Dr. Urs Wyder), Polymers (Ing. Guido Smets) and Life Sciences (Dr. Joost Schoeber and Dr. Anne Loonen).
The Life Science group mainly focuses on the development, optimization, and validation of molecular diagnostic assays to improve health. Currently, the group is working on developing innovative molecular assays to screen for sexually transmitted diseases in patients and wastewater (mirror of society).
Anouk Poppelaars is doing her bachelor’s thesis at the Life Science department and her main goal is to develop an ultrafast next-generation PCR protocol for the detection of Chlamydia trachomatis (CT). To show her research results, she presented a poster at the BAMA Symposium 2022, organized by the Microbes in Health and Diseases (MHD), University of Groningen. Anouk won three different Prizes: A poster award, and jury and audience prizes.
Chlamydia trachomatis (CT) infections happen more often than we think and patients can also be asymptomatic (over 64.000 positive test results in The Netherlands in 2022, RIVM STD report 2022). Molecular diagnostics are the gold standard for diagnosing CT. However, as samples have to be sent to the laboratory, it can take a few days before the results are reported back to the patient. This means that the patient has to travel to the general practitioner or sexual health center at least twice and cannot be treated immediately. In some cases, it might happen that a doctor feels the need to prescribe antibiotics before knowing the test results.
The different bottlenecks that Chlamydia infection presents can be divided into two different parts, which determine the two different goals of the project:
Clinical samples were collected and prepared for detection in 96 well plates, which were sealed in the Plate sealer and incorporated into the NextGenPCR. It is an instrument developed by Molecular Biology Systems (MBS), which elimiantes ramping rates when changing temperatures. Therefore, the instrument goes from melting to annealing temperatures in less than 0.1 second. As a consequence, the higher speed enables to process more samples with the best solution for high throughput. Furthermore, it consumes only 25 watts, so helps researchers to save energy costs.
NextGenPCR is used in the project for the amplification of CT genetic material. The amplification signal is read with the FLUOstar plate reader from BMG Labtech and later analysed with Excel.
Due to NextGenPCR, the time-to-result for CT from patient material has been accelerated compared to conventional real-time PCR. By using the same protocol as the conventional real-time PCR on the NextGenPCR platform results were available 30% faster. This can be explained by the fact that the NextGenPCR system transfers the PCR plates to different heating blocks at set temperatures (no heating and cooling is necessary).
Nevertheless, after the optimization of NextGenPCR protocols for CT, an additional decrease was accomplished resulting in CT results after approximately 17 minutes.
With reducing PCR cycles from 45 to 30, and therefore having shorter protocol time, RFU remains high significantly. NTC= No template control.
The findings highlighted above show that:
+31 30 6880771
support@isogen-lifescience.com
Veldzigt 2A
3454 PW De Meern
